ZIVO BIOSCIENCE INC (ZIVO) analyst actions
Rating and price-target actions on ZIVO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ZIVO overview →
1 measured ZIVO analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens | Press release | +15.04% | +1.56% |
Keep exploring
More ZIVO: earnings → · SEC filings → · ZIVO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EISAI CO LTD (ESALF) | 122 | 0.00% | 7% |
| WAYLAND GROUP CORP ORD (MRRCF) | 122 | -0.44% | 40% |
| American Shared Hospital Services (AMS) | 121 | 0.00% | 48% |
| Protagenic Therapeutics, Inc. (PTIX) | 121 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.